About EndoChoice
EndoChoice is a company based in Alpharetta (United States) founded in 2008 was acquired by Boston Scientific in September 2016.. EndoChoice has raised $115.96 million across 7 funding rounds from investors including Boston Scientific, SVB and MidCap Financial. The company has 414 employees as of December 31, 2016. EndoChoice has completed 1 acquisition, including Peer Medical. EndoChoice operates in a competitive market with competitors including EndoGastric Solutions, CoapTech, SafeStitch, Endo Tools Therapeutics and EndoStim, among others.
- Headquarter Alpharetta, United States
- Employees 414 as on 31 Dec, 2016
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Endochoice Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$115.96 M (USD)
in 7 rounds
-
Latest Funding Round
$58 M (USD), Debt – Conventional
Jun 30, 2015
-
Investors
Boston Scientific
& 9 more
-
Employee Count
414
as on Dec 31, 2016
- Investments & Acquisitions
-
Acquired by
Boston Scientific
(Sep 27, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of EndoChoice
EndoChoice has successfully raised a total of $115.96M across 7 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $58 million completed in June 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Debt – Conventional — $58.0M
-
First Round
First Round
(19 May 2008)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2015 | Amount | Debt – Conventional - EndoChoice | Valuation |
investors |
|
| Mar, 2015 | Amount | Series E - EndoChoice | Valuation |
investors |
|
| Jan, 2013 | Amount | Series D - EndoChoice | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in EndoChoice
EndoChoice has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Boston Scientific, SVB and MidCap Financial. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private debt funds are managed across multiple sectors.
|
Founded Year | Domain | Location | |
|
Early-stage and late-stage biotech and finance companies are funded.
|
Founded Year | Domain | Location | |
|
Sequoia Capital is engaged in venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by EndoChoice
EndoChoice has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Peer Medical. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Gastrointestinal endoscopy technology for bowel cancer diagnosis was developed.
|
2009 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - EndoChoice
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Endochoice Comparisons
Competitors of EndoChoice
EndoChoice operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EndoGastric Solutions, CoapTech, SafeStitch, Endo Tools Therapeutics and EndoStim, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Incisionless transoral procedures for upper GI diseases are developed.
|
|
| domain | founded_year | HQ Location |
Minimally invasive gastrostomy feeding tube placement method is developed.
|
|
| domain | founded_year | HQ Location |
Medical devices for gastrointestinal and bariatric surgery are developed.
|
|
| domain | founded_year | HQ Location |
Endoscopic catheters for precision in gastroenterology are developed.
|
|
| domain | founded_year | HQ Location |
Implant to treat GERD
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about EndoChoice
When was EndoChoice founded?
EndoChoice was founded in 2008.
Where is EndoChoice located?
EndoChoice is headquartered in Alpharetta, United States. It is registered at Alpharetta, Georgia, United States.
Is EndoChoice a funded company?
EndoChoice is a funded company, having raised a total of $115.96M across 7 funding rounds to date. The company's 1st funding round was a Series D of $43M, raised on May 19, 2008.
How many employees does EndoChoice have?
As of Dec 31, 2016, the latest employee count at EndoChoice is 414.
What does EndoChoice do?
EndoChoice was founded in 2008 and is based in Alpharetta, United States. Operations focus on the gastrointestinal sector, where devices, diagnostics, infection control measures, and imaging tools are supplied to specialists addressing GI conditions. A public listing on the stock exchange was completed in June 2015, supporting expansion in medical technology for digestive health.
Who are the top competitors of EndoChoice?
EndoChoice's top competitors include CoapTech, Endo Tools Therapeutics and EndoGastric Solutions.
How many acquisitions has EndoChoice made?
EndoChoice has made 1 acquisition, including Peer Medical.
Who are EndoChoice's investors?
EndoChoice has 10 investors. Key investors include Boston Scientific, SVB, MidCap Financial, Rock Springs Capital, and Sequoia Capital.